Literature DB >> 24401662

Clinical and genetic evaluation of patients with KATP channel mutations from the German registry for congenital hyperinsulinism.

Klaus Mohnike1, Ilse Wieland, Winfried Barthlen, Silke Vogelgesang, Susann Empting, Wolfgang Mohnike, Thomas Meissner, Martin Zenker.   

Abstract

Congenital hyperinsulinism (CHI) causes hypoglycemia due to irregular insulin secretion. In infants, a rapid diagnosis and appropriate management to avoid severe hypoglycemia is mandatory. CHI is a heterogeneous condition at the clinical and genetic level, and disease-causing genes have been identified in about half of the patients. The majority of mutations have been identified in the ABCC8 and KCNJ11 genes encoding subunits of the KATP channel responsible for two distinct histological forms. The diffuse form is caused by autosomal recessive or dominant inherited mutations, whereas the focal form is caused by a paternally transmitted recessive mutation and a second somatic event. We report on an unselected cohort of 136 unrelated patients from the German CHI registry. Mutations in either the ABCC8 or KCNJ11 gene were identified in 61 of these patients (45%). In total, 64 different mutations including 38 novel ones were detected in this cohort. We observed biparental (recessive) inheritance in 34% of mutation-positive patients, dominant inheritance in 11% and paternal transmission of a mutation associated with a focal CHI type in 38%. In addition, we observed inheritance patterns that do not exactly follow the classical recessive or dominant mode, further adding to the genetic complexity of this disease.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24401662     DOI: 10.1159/000356905

Source DB:  PubMed          Journal:  Horm Res Paediatr        ISSN: 1663-2818            Impact factor:   2.852


  14 in total

1.  Multiplexing DNA methylation markers to detect circulating cell-free DNA derived from human pancreatic β cells.

Authors:  Daniel Neiman; David Gillis; Sheina Piyanzin; Daniel Cohen; Ori Fridlich; Joshua Moss; Aviad Zick; Tal Oron; Frida Sundberg; Gun Forsander; Oskar Skog; Olle Korsgren; Floris Levy-Khademi; Dan Arbel; Saar Hashavia; A M James Shapiro; Cate Speake; Carla Greenbaum; Jennifer Hosford; Amanda Posgai; Mark A Atkinson; Benjamin Glaser; Desmond A Schatz; Ruth Shemer; Yuval Dor
Journal:  JCI Insight       Date:  2020-07-23

2.  Molecular genetic testing of patients with monogenic diabetes and hyperinsulinism.

Authors:  James T Bennett; Valeria Vasta; Min Zhang; Jaya Narayanan; Peter Gerrits; Si Houn Hahn
Journal:  Mol Genet Metab       Date:  2014-12-20       Impact factor: 4.797

3.  Conservatively treated Congenital Hyperinsulinism (CHI) due to K-ATP channel gene mutations: reducing severity over time.

Authors:  Maria Salomon-Estebanez; Sarah E Flanagan; Sian Ellard; Lindsey Rigby; Louise Bowden; Zainab Mohamed; Jacqueline Nicholson; Mars Skae; Caroline Hall; Ross Craigie; Raja Padidela; Nuala Murphy; Tabitha Randell; Karen E Cosgrove; Mark J Dunne; Indraneel Banerjee
Journal:  Orphanet J Rare Dis       Date:  2016-12-01       Impact factor: 4.123

4.  A Case Series: Congenital Hyperinsulinism.

Authors:  Mohammad Reza Alaei; Susan Akbaroghli; Mohammad Keramatipour; Ali Alaei
Journal:  Int J Endocrinol Metab       Date:  2016-09-10

Review 5.  Update of variants identified in the pancreatic β-cell KATP channel genes KCNJ11 and ABCC8 in individuals with congenital hyperinsulinism and diabetes.

Authors:  Elisa De Franco; Cécile Saint-Martin; Klaus Brusgaard; Amy E Knight Johnson; Lydia Aguilar-Bryan; Pamela Bowman; Jean-Baptiste Arnoux; Annette Rønholt Larsen; May Sanyoura; Siri Atma W Greeley; Raúl Calzada-León; Bradley Harman; Jayne A L Houghton; Elisa Nishimura-Meguro; Thomas W Laver; Sian Ellard; Daniela Del Gaudio; Henrik Thybo Christesen; Christine Bellanné-Chantelot; Sarah E Flanagan
Journal:  Hum Mutat       Date:  2020-02-17       Impact factor: 4.878

6.  Whole‑exome sequencing in Russian children with non‑type 1 diabetes mellitus reveals a wide spectrum of genetic variants in MODY‑related and unrelated genes.

Authors:  Oleg S Glotov; Elena A Serebryakova; Mariia E Turkunova; Olga A Efimova; Andrey S Glotov; Yury A Barbitoff; Yulia A Nasykhova; Alexander V Predeus; Dmitrii E Polev; Mikhail A Fedyakov; Irina V Polyakova; Tatyana E Ivashchenko; Natalia Y Shved; Elena S Shabanova; Alena V Tiselko; Olga V Romanova; Andrey M Sarana; Anna A Pendina; Sergey G Scherbak; Ekaterina V Musina; Anastasiia V Petrovskaia-Kaminskaia; Liubov R Lonishin; Liliya V Ditkovskaya; Liudmila А Zhelenina; Ludmila V Tyrtova; Olga S Berseneva; Rostislav K Skitchenko; Evgenii N Suspitsin; Elena B Bashnina; Vladislav S Baranov
Journal:  Mol Med Rep       Date:  2019-10-16       Impact factor: 2.952

Review 7.  Disease Associated Mutations in KIR Proteins Linked to Aberrant Inward Rectifier Channel Trafficking.

Authors:  Eva-Maria Zangerl-Plessl; Muge Qile; Meye Bloothooft; Anna Stary-Weinzinger; Marcel A G van der Heyden
Journal:  Biomolecules       Date:  2019-10-25

Review 8.  Congenital hyperinsulinism: current status and future perspectives.

Authors:  Tohru Yorifuji
Journal:  Ann Pediatr Endocrinol Metab       Date:  2014-06-30

9.  Enhanced Islet Cell Nucleomegaly Defines Diffuse Congenital Hyperinsulinism in Infancy but Not Other Forms of the Disease.

Authors:  Bing Han; Melanie Newbould; Gauri Batra; Edmund Cheesman; Ross J Craigie; Zainab Mohamed; Lindsey Rigby; Raja Padidela; Mars Skae; Aleksandr Mironov; Tobias Starborg; Karl E Kadler; Karen E Cosgrove; Indraneel Banerjee; Mark J Dunne
Journal:  Am J Clin Pathol       Date:  2016-06       Impact factor: 2.493

Review 10.  Genetic testing in inherited endocrine disorders: joint position paper of the European reference network on rare endocrine conditions (Endo-ERN).

Authors:  Thomas Eggermann; Miriam Elbracht; Ingo Kurth; Anders Juul; Trine Holm Johannsen; Irène Netchine; George Mastorakos; Gudmundur Johannsson; Thomas J Musholt; Martin Zenker; Dirk Prawitt; Alberto M Pereira; Olaf Hiort
Journal:  Orphanet J Rare Dis       Date:  2020-06-08       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.